LY-364947
Code | Size | Price |
---|
TAR-T2048-5mg | 5mg | £119.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2048-1mL | 1 mL * 10 mM (in DMSO) | £125.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2048-10mg | 10mg | £132.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2048-25mg | 25mg | £196.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2048-50mg | 50mg | £289.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2048-100mg | 100mg | £390.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T2048-200mg | 200mg | £551.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
LY364947 is a potent ATP-competitive inhibitor of TGFβR-I.
CAS:
396129-53-6
Formula:
C17H12N4
Molecular Weight:
272.311
Pathway:
Metabolism; MAPK; Stem Cells; NF-κb; Apoptosis
Purity:
0.9996
SMILES:
c1[nH]nc(c1-c1ccnc2ccccc12)-c1ccccn1
Target:
MLK; Casein Kinase; TGF-beta/Smad; RIP kinase
References
1. Li HY, et al. J Med Chem, 2006, 49(6), 2138-2142.
2. Vogt J, et al. Cell Signal, 2011, 23(11), 1831-1842.
3. Peng SB, et al. Biochemistry, 2005, 44(7), 2293-2304.
4. Oka M, et al. Blood, 2008, 111(9), 4571-4579.
5. Naka K, et al. Nature, 2010, 463(7281), 676-680.
6. Deng Y, Li L, Zhu J H, et al. COX-2 promotes the osteogenic potential of BMP9 through TGF-?1/p38 signaling in mesenchymal stem cells[J]. Aging (Albany NY) . 2021, 13(8): 11336.
7. Chen Q Z, Li Y, Shao Y, et al. TGF-?1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells [J]. International journal of oncology. 2017, 50(3): 1011-1021.
8. Li Q, Ma Y, Liu X L, et al. Anti?proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF??1/p53 signaling pathway[J]. Oncology Reports. 2020